Long only, momentum, event-driven

Buy Santarus And Get Future Indications Plus Pipeline For Free

If you missed the incredible run up in share price that Santarus (NASDAQ:SNTS) has achieved over the past 18 months, now may be the perfect time to ride the next wave up. Santarus has been one of the strongest stocks in the biotech sector this year with a YTD increase over 350%. The dramatic price increase has been driven by several positive catalysts as described below. Despite this stellar performance, a series of events has contributed to a recent sell off, opening the door for investors to buy shares at a deeply discounted price. In this article I will explain why I believe near term indications with both commercial and pipeline products could alone, be worth significantly more...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details